Company chart and information is provided by TradingView based on 15-minute-delayed data.
Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex. It has also completed the development program for DWP-450 for the treatment of moderate to severe glabellar lines.
| Website: | www.evolus.com |
| Email: | IR@Evolus.com |
| Main Phone: | +1 949 284-4555 |
| Address: | 520 Newport Center Drive |
| Address 2: | Suite 1200 |
| State: | CA |
| City / Town: | Newport Beach |
| Country: | US |
| Postal Code: | 92660 |
| Exchange: | NSD |
| CEO: | David Moatazedi |
| Employees: | 119 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
